We are in the process of putting together the SDEF's Las Vegas Dermatology Seminar and optional Cutaneous Malignancies Forum programs.
Please SIGN UP for email updates to keep informed of program developments for our upcoming conference as they become available.
Learning Objectives 2019
At the conclusion of this live conference, learners should be better able to:
- Design a comprehensive treatment plan for acne patients based on clinical guidelines, incorporating pharmacologic and nonpharmacologic strategies.
- Discuss the clinical relevance of the most recent research on the etiologies and therapy of acne vulgaris.
- Review the topical treatment pipeline for acne.
- Identify risk factors for actinic keratosis.
- Design individualized treatment strategies for patients with actinic keratosis to reduce risk of squamous cell carcinoma.
- Determine which laser and energy-based devices can be safely used sequentially and in combination.
- Explain methods to increase patient satisfaction and improve patient outcomes via combination treatments for facial rejuvenation.
- Discuss which injectables can be used in combination with laser and energy-based devices to safely improve patient outcomes.
- Describe the technology behind the various tissue tightening devices.
- Explain appropriate patient selection for tissue tightening techniques to achieve optimal cosmetic outcomes and patient satisfaction.
- Recognize complications and how to avoid them in the use of tissue tightening devices.
- Describe facial anatomy for safe injection of soft-tissue fillers.
- Recognize and manage complications that can occur with injection of soft tissue fillers.
- Perform injection techniques and proper filler placement to achieve optimal patient outcomes.
- Describe the technology behind the various products and devices available for noninvasive body contouring.
- Demonstrate appropriate patient selection for body contouring techniques to achieve optimal cosmetic outcomes and improve patient satisfaction.
- Recognize, avoid, and manage possible complications that can occur with various noninvasive body contouring techniques.
- Design evidence-based, guideline-driven treatment strategies for patients with atopic dermatitis based on disease severity with the goal of clear or almost clear skin.
- Incorporate strategies for use of use of new therapies aimed at blocking the inflammatory mediators of atopic dermatitis.
- Identify which allergens are likely to be problematic for patients with atopy and integrate patch testing when appropriate.
- Identify cutaneous manifestations of connective tissue disease and determine appropriate management strategies.
- Describe evidence-based strategies for the diagnosis and pharmacologic management of hyperhidrosis.
- Discuss the current systemic and topical therapies for onychomycosis and tinea fungal infections.
- Diagnose and develop treatment strategies for hyper- and hypo-pigmentation disorders.
- Describe the pathophysiology of psoriasis and its associated comorbidities.
- Diagnose and treat patients with psoriasis appropriately, based on current clinical guidelines.
- Design treatment strategies that incorporate biologic therapies into the management of appropriately selected patients with psoriasis.
- Increase routine screening for psoriatic arthritis in patients with psoriasis.
- Develop strategies to increase screening for and management of comorbidities of psoriasis, including cardiovascular and psychiatric disorders.
- Design self-education and patient education programs as part of the treatment plan for rosacea treatment.
- Discuss appropriate treatment strategies for rosacea, based on individual signs and symptoms as well as knowledge of the indications, efficacy, and risks of available and emerging rosacea therapies.
- Differentiate seborrheic keratosis from other skin lesions, particularly melanoma.
- Match patients with the most appropriate interventions for effective and cosmetically acceptable treatment of SK lesions.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and Skin Disease Education Foundation/Global Academy for Medical Education, LLC. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.
The University of Louisville Office of Continuing Medical Education & Professional Development designates this live activity for a maximum of 16.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This Live activity, Skin Disease Education Foundation's 20th Las Vegas Dermatology Seminar and Annual Psoriasis and Atopic Dermatology Forums, with a beginning date of 11/07/2019, has been reviewed and is acceptable for up to 15.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The self-assessment program offered at the Skin Disease Education Foundation’s 20th Las Vegas Dermatology Seminar® is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points.
NURSING AND PHARMACY
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 16.75 contact hours (1.675 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 16.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.